nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Epirubicin—stomach cancer	0.263	0.519	CrCtD
Valrubicin—Doxorubicin—stomach cancer	0.244	0.481	CrCtD
Valrubicin—TOP2A—Epirubicin—stomach cancer	0.0923	0.653	CbGbCtD
Valrubicin—Daunorubicin—Epirubicin—stomach cancer	0.0563	0.173	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—stomach cancer	0.0563	0.173	CrCrCtD
Valrubicin—Idarubicin—Epirubicin—stomach cancer	0.0563	0.173	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—stomach cancer	0.0521	0.16	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—stomach cancer	0.0521	0.16	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—stomach cancer	0.0521	0.16	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—stomach cancer	0.0491	0.347	CbGbCtD
Valrubicin—Skin irritation—Fluorouracil—stomach cancer	0.00059	0.0251	CcSEcCtD
Valrubicin—Doxorubicin—AKR1C3—stomach cancer	0.000524	0.613	CrCbGaD
Valrubicin—Local reaction—Fluorouracil—stomach cancer	0.000461	0.0196	CcSEcCtD
Valrubicin—TOP2A—Topotecan—Irinotecan—stomach cancer	0.000422	0.279	CbGdCrCtD
Valrubicin—Proctalgia—Capecitabine—stomach cancer	0.00038	0.0162	CcSEcCtD
Valrubicin—Rectal tenesmus—Epirubicin—stomach cancer	0.000334	0.0142	CcSEcCtD
Valrubicin—Doxorubicin—NOS3—stomach cancer	0.000331	0.387	CrCbGaD
Valrubicin—Ill-defined disorder—Floxuridine—stomach cancer	0.000317	0.0135	CcSEcCtD
Valrubicin—Anaemia—Floxuridine—stomach cancer	0.000316	0.0134	CcSEcCtD
Valrubicin—Rectal tenesmus—Doxorubicin—stomach cancer	0.000309	0.0131	CcSEcCtD
Valrubicin—Malaise—Floxuridine—stomach cancer	0.000308	0.0131	CcSEcCtD
Valrubicin—Vasodilation procedure—Irinotecan—stomach cancer	0.000303	0.0129	CcSEcCtD
Valrubicin—Vasodilation—Irinotecan—stomach cancer	0.000303	0.0129	CcSEcCtD
Valrubicin—TOP2A—Paclitaxel—Docetaxel—stomach cancer	0.000296	0.196	CbGdCrCtD
Valrubicin—Discomfort—Floxuridine—stomach cancer	0.000288	0.0122	CcSEcCtD
Valrubicin—Proctalgia—Epirubicin—stomach cancer	0.000265	0.0113	CcSEcCtD
Valrubicin—Ill-defined disorder—Mitomycin—stomach cancer	0.000249	0.0106	CcSEcCtD
Valrubicin—Anaemia—Mitomycin—stomach cancer	0.000248	0.0105	CcSEcCtD
Valrubicin—Proctalgia—Doxorubicin—stomach cancer	0.000245	0.0104	CcSEcCtD
Valrubicin—Malaise—Mitomycin—stomach cancer	0.000242	0.0103	CcSEcCtD
Valrubicin—Feeling abnormal—Floxuridine—stomach cancer	0.00023	0.00978	CcSEcCtD
Valrubicin—Gastrointestinal pain—Floxuridine—stomach cancer	0.000228	0.00971	CcSEcCtD
Valrubicin—Ageusia—Docetaxel—stomach cancer	0.000227	0.00968	CcSEcCtD
Valrubicin—Anorectal discomfort—Epirubicin—stomach cancer	0.000227	0.00967	CcSEcCtD
Valrubicin—Discomfort—Mitomycin—stomach cancer	0.000226	0.0096	CcSEcCtD
Valrubicin—Local reaction—Epirubicin—stomach cancer	0.000224	0.00955	CcSEcCtD
Valrubicin—Abdominal pain—Floxuridine—stomach cancer	0.000221	0.00938	CcSEcCtD
Valrubicin—Body temperature increased—Floxuridine—stomach cancer	0.000221	0.00938	CcSEcCtD
Valrubicin—TOP2A—Cladribine—Floxuridine—stomach cancer	0.00022	0.146	CbGdCrCtD
Valrubicin—Ageusia—Capecitabine—stomach cancer	0.00022	0.00937	CcSEcCtD
Valrubicin—Anorectal discomfort—Doxorubicin—stomach cancer	0.00021	0.00895	CcSEcCtD
Valrubicin—Local reaction—Doxorubicin—stomach cancer	0.000208	0.00884	CcSEcCtD
Valrubicin—Pelvic pain—Epirubicin—stomach cancer	0.000204	0.00869	CcSEcCtD
Valrubicin—Asthenia—Floxuridine—stomach cancer	0.0002	0.00852	CcSEcCtD
Valrubicin—Nocturia—Capecitabine—stomach cancer	0.000192	0.00818	CcSEcCtD
Valrubicin—Diarrhoea—Floxuridine—stomach cancer	0.000191	0.00812	CcSEcCtD
Valrubicin—Pelvic pain—Doxorubicin—stomach cancer	0.000189	0.00804	CcSEcCtD
Valrubicin—Feeling abnormal—Mitomycin—stomach cancer	0.00018	0.00768	CcSEcCtD
Valrubicin—Vomiting—Floxuridine—stomach cancer	0.000177	0.00755	CcSEcCtD
Valrubicin—Irritability—Fluorouracil—stomach cancer	0.000177	0.00752	CcSEcCtD
Valrubicin—Rash—Floxuridine—stomach cancer	0.000176	0.00749	CcSEcCtD
Valrubicin—Dermatitis—Floxuridine—stomach cancer	0.000176	0.00748	CcSEcCtD
Valrubicin—Headache—Floxuridine—stomach cancer	0.000175	0.00744	CcSEcCtD
Valrubicin—Body temperature increased—Mitomycin—stomach cancer	0.000173	0.00736	CcSEcCtD
Valrubicin—Urinary incontinence—Capecitabine—stomach cancer	0.000172	0.00733	CcSEcCtD
Valrubicin—Nausea—Floxuridine—stomach cancer	0.000166	0.00705	CcSEcCtD
Valrubicin—Asthenia—Mitomycin—stomach cancer	0.000157	0.00668	CcSEcCtD
Valrubicin—Ageusia—Epirubicin—stomach cancer	0.000153	0.00653	CcSEcCtD
Valrubicin—Pneumonia—Irinotecan—stomach cancer	0.00015	0.00638	CcSEcCtD
Valrubicin—Diarrhoea—Mitomycin—stomach cancer	0.00015	0.00637	CcSEcCtD
Valrubicin—Dizziness—Mitomycin—stomach cancer	0.000145	0.00616	CcSEcCtD
Valrubicin—Pneumonia—Fluorouracil—stomach cancer	0.000144	0.00611	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—stomach cancer	0.000142	0.00604	CcSEcCtD
Valrubicin—Vasodilation—Epirubicin—stomach cancer	0.000141	0.00602	CcSEcCtD
Valrubicin—Vasodilation procedure—Epirubicin—stomach cancer	0.000141	0.00602	CcSEcCtD
Valrubicin—Vomiting—Mitomycin—stomach cancer	0.000139	0.00592	CcSEcCtD
Valrubicin—Urinary tract infection—Fluorouracil—stomach cancer	0.000139	0.00591	CcSEcCtD
Valrubicin—Rash—Mitomycin—stomach cancer	0.000138	0.00587	CcSEcCtD
Valrubicin—Dermatitis—Mitomycin—stomach cancer	0.000138	0.00587	CcSEcCtD
Valrubicin—Headache—Mitomycin—stomach cancer	0.000137	0.00584	CcSEcCtD
Valrubicin—Nocturia—Epirubicin—stomach cancer	0.000134	0.0057	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—stomach cancer	0.000131	0.00557	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—stomach cancer	0.000131	0.00557	CcSEcCtD
Valrubicin—Nausea—Mitomycin—stomach cancer	0.00013	0.00553	CcSEcCtD
Valrubicin—Cystitis noninfective—Methotrexate—stomach cancer	0.00013	0.00552	CcSEcCtD
Valrubicin—Cystitis—Methotrexate—stomach cancer	0.000128	0.00546	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—stomach cancer	0.000124	0.00527	CcSEcCtD
Valrubicin—Irritability—Capecitabine—stomach cancer	0.000124	0.00526	CcSEcCtD
Valrubicin—Urinary retention—Capecitabine—stomach cancer	0.000123	0.00524	CcSEcCtD
Valrubicin—Cystitis noninfective—Epirubicin—stomach cancer	0.000121	0.00516	CcSEcCtD
Valrubicin—Bladder pain—Methotrexate—stomach cancer	0.00012	0.00511	CcSEcCtD
Valrubicin—Cystitis—Epirubicin—stomach cancer	0.00012	0.00511	CcSEcCtD
Valrubicin—Blood urea increased—Epirubicin—stomach cancer	0.000117	0.00499	CcSEcCtD
Valrubicin—Flatulence—Irinotecan—stomach cancer	0.000115	0.00488	CcSEcCtD
Valrubicin—Back pain—Irinotecan—stomach cancer	0.000113	0.00479	CcSEcCtD
Valrubicin—Bladder pain—Epirubicin—stomach cancer	0.000112	0.00478	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—stomach cancer	0.000112	0.00478	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—stomach cancer	0.000111	0.00472	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—stomach cancer	0.000109	0.00462	CcSEcCtD
Valrubicin—Ill-defined disorder—Irinotecan—stomach cancer	0.000108	0.0046	CcSEcCtD
Valrubicin—Anaemia—Irinotecan—stomach cancer	0.000108	0.00458	CcSEcCtD
Valrubicin—Malaise—Irinotecan—stomach cancer	0.000105	0.00447	CcSEcCtD
Valrubicin—Dysuria—Capecitabine—stomach cancer	0.000105	0.00445	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—stomach cancer	0.000104	0.00442	CcSEcCtD
Valrubicin—Pneumonia—Docetaxel—stomach cancer	0.000104	0.00441	CcSEcCtD
Valrubicin—Anaemia—Fluorouracil—stomach cancer	0.000103	0.00439	CcSEcCtD
Valrubicin—Hyperglycaemia—Capecitabine—stomach cancer	0.000101	0.0043	CcSEcCtD
Valrubicin—Pneumonia—Capecitabine—stomach cancer	0.0001	0.00427	CcSEcCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—stomach cancer	9.92e-05	0.0656	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—stomach cancer	9.92e-05	0.0656	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—stomach cancer	9.92e-05	0.0656	CbGdCrCtD
Valrubicin—Discomfort—Irinotecan—stomach cancer	9.8e-05	0.00417	CcSEcCtD
Valrubicin—Urinary tract infection—Capecitabine—stomach cancer	9.7e-05	0.00413	CcSEcCtD
Valrubicin—Haematuria—Capecitabine—stomach cancer	9.51e-05	0.00405	CcSEcCtD
Valrubicin—Chest pain—Fluorouracil—stomach cancer	9.5e-05	0.00404	CcSEcCtD
Valrubicin—Myalgia—Fluorouracil—stomach cancer	9.5e-05	0.00404	CcSEcCtD
Valrubicin—Discomfort—Fluorouracil—stomach cancer	9.39e-05	0.00399	CcSEcCtD
Valrubicin—Irritability—Methotrexate—stomach cancer	9.2e-05	0.00391	CcSEcCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—stomach cancer	9.18e-05	0.0607	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—stomach cancer	9.18e-05	0.0607	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—stomach cancer	9.18e-05	0.0607	CbGdCrCtD
Valrubicin—Oedema peripheral—Docetaxel—stomach cancer	9.11e-05	0.00388	CcSEcCtD
Valrubicin—Oedema peripheral—Capecitabine—stomach cancer	8.82e-05	0.00375	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	8.3e-05	0.00353	CcSEcCtD
Valrubicin—Feeling abnormal—Irinotecan—stomach cancer	7.84e-05	0.00333	CcSEcCtD
Valrubicin—Back pain—Docetaxel—stomach cancer	7.79e-05	0.00331	CcSEcCtD
Valrubicin—Dysuria—Methotrexate—stomach cancer	7.79e-05	0.00331	CcSEcCtD
Valrubicin—Gastrointestinal pain—Irinotecan—stomach cancer	7.78e-05	0.00331	CcSEcCtD
Valrubicin—Flatulence—Capecitabine—stomach cancer	7.68e-05	0.00327	CcSEcCtD
Valrubicin—Back pain—Capecitabine—stomach cancer	7.54e-05	0.00321	CcSEcCtD
Valrubicin—Body temperature increased—Irinotecan—stomach cancer	7.52e-05	0.0032	CcSEcCtD
Valrubicin—Abdominal pain—Irinotecan—stomach cancer	7.52e-05	0.0032	CcSEcCtD
Valrubicin—Feeling abnormal—Fluorouracil—stomach cancer	7.5e-05	0.00319	CcSEcCtD
Valrubicin—Pneumonia—Methotrexate—stomach cancer	7.47e-05	0.00318	CcSEcCtD
Valrubicin—Anaemia—Docetaxel—stomach cancer	7.44e-05	0.00317	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—stomach cancer	7.29e-05	0.0031	CcSEcCtD
Valrubicin—Ill-defined disorder—Capecitabine—stomach cancer	7.24e-05	0.00308	CcSEcCtD
Valrubicin—Anaemia—Capecitabine—stomach cancer	7.21e-05	0.00307	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—stomach cancer	7.2e-05	0.00306	CcSEcCtD
Valrubicin—Body temperature increased—Fluorouracil—stomach cancer	7.2e-05	0.00306	CcSEcCtD
Valrubicin—Haematuria—Methotrexate—stomach cancer	7.08e-05	0.00301	CcSEcCtD
Valrubicin—Hyperglycaemia—Epirubicin—stomach cancer	7.03e-05	0.00299	CcSEcCtD
Valrubicin—Malaise—Capecitabine—stomach cancer	7.03e-05	0.00299	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—stomach cancer	6.99e-05	0.00297	CcSEcCtD
Valrubicin—Chest pain—Docetaxel—stomach cancer	6.86e-05	0.00292	CcSEcCtD
Valrubicin—Myalgia—Docetaxel—stomach cancer	6.86e-05	0.00292	CcSEcCtD
Valrubicin—Asthenia—Irinotecan—stomach cancer	6.82e-05	0.0029	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—stomach cancer	6.76e-05	0.00287	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—stomach cancer	6.75e-05	0.00287	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—stomach cancer	6.66e-05	0.00284	CcSEcCtD
Valrubicin—Chest pain—Capecitabine—stomach cancer	6.64e-05	0.00282	CcSEcCtD
Valrubicin—Myalgia—Capecitabine—stomach cancer	6.64e-05	0.00282	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—stomach cancer	6.63e-05	0.00282	CcSEcCtD
Valrubicin—Discomfort—Capecitabine—stomach cancer	6.56e-05	0.00279	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—stomach cancer	6.51e-05	0.00277	CcSEcCtD
Valrubicin—Diarrhoea—Irinotecan—stomach cancer	6.51e-05	0.00277	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—stomach cancer	6.47e-05	0.00275	CcSEcCtD
Valrubicin—Pruritus—Fluorouracil—stomach cancer	6.44e-05	0.00274	CcSEcCtD
Valrubicin—Dizziness—Irinotecan—stomach cancer	6.29e-05	0.00268	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—stomach cancer	6.25e-05	0.00266	CcSEcCtD
Valrubicin—Diarrhoea—Fluorouracil—stomach cancer	6.23e-05	0.00265	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—stomach cancer	6.15e-05	0.00262	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—stomach cancer	6.13e-05	0.00261	CcSEcCtD
Valrubicin—Vomiting—Irinotecan—stomach cancer	6.05e-05	0.00257	CcSEcCtD
Valrubicin—Dizziness—Fluorouracil—stomach cancer	6.02e-05	0.00256	CcSEcCtD
Valrubicin—Rash—Irinotecan—stomach cancer	6e-05	0.00255	CcSEcCtD
Valrubicin—Dermatitis—Irinotecan—stomach cancer	5.99e-05	0.00255	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Docetaxel—stomach cancer	5.99e-05	0.00255	CcSEcCtD
Valrubicin—Headache—Irinotecan—stomach cancer	5.96e-05	0.00253	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.8e-05	0.00247	CcSEcCtD
Valrubicin—Vomiting—Fluorouracil—stomach cancer	5.79e-05	0.00246	CcSEcCtD
Valrubicin—Rash—Fluorouracil—stomach cancer	5.74e-05	0.00244	CcSEcCtD
Valrubicin—Dermatitis—Fluorouracil—stomach cancer	5.74e-05	0.00244	CcSEcCtD
Valrubicin—Headache—Fluorouracil—stomach cancer	5.71e-05	0.00243	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—stomach cancer	5.69e-05	0.00242	CcSEcCtD
Valrubicin—Nausea—Irinotecan—stomach cancer	5.65e-05	0.0024	CcSEcCtD
Valrubicin—Back pain—Methotrexate—stomach cancer	5.62e-05	0.00239	CcSEcCtD
Valrubicin—Feeling abnormal—Docetaxel—stomach cancer	5.42e-05	0.0023	CcSEcCtD
Valrubicin—Nausea—Fluorouracil—stomach cancer	5.41e-05	0.0023	CcSEcCtD
Valrubicin—Ill-defined disorder—Methotrexate—stomach cancer	5.39e-05	0.00229	CcSEcCtD
Valrubicin—Gastrointestinal pain—Docetaxel—stomach cancer	5.38e-05	0.00229	CcSEcCtD
Valrubicin—Anaemia—Methotrexate—stomach cancer	5.37e-05	0.00228	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—stomach cancer	5.35e-05	0.00228	CcSEcCtD
Valrubicin—Back pain—Epirubicin—stomach cancer	5.25e-05	0.00224	CcSEcCtD
Valrubicin—Feeling abnormal—Capecitabine—stomach cancer	5.24e-05	0.00223	CcSEcCtD
Valrubicin—Malaise—Methotrexate—stomach cancer	5.23e-05	0.00223	CcSEcCtD
Valrubicin—Gastrointestinal pain—Capecitabine—stomach cancer	5.2e-05	0.00221	CcSEcCtD
Valrubicin—Abdominal pain—Docetaxel—stomach cancer	5.2e-05	0.00221	CcSEcCtD
Valrubicin—Body temperature increased—Docetaxel—stomach cancer	5.2e-05	0.00221	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—stomach cancer	5.04e-05	0.00214	CcSEcCtD
Valrubicin—Abdominal pain—Capecitabine—stomach cancer	5.03e-05	0.00214	CcSEcCtD
Valrubicin—Body temperature increased—Capecitabine—stomach cancer	5.03e-05	0.00214	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—stomach cancer	5.02e-05	0.00214	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—stomach cancer	4.95e-05	0.00211	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—stomach cancer	4.94e-05	0.0021	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—stomach cancer	4.94e-05	0.0021	CcSEcCtD
Valrubicin—Malaise—Epirubicin—stomach cancer	4.9e-05	0.00208	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—stomach cancer	4.88e-05	0.00208	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—stomach cancer	4.86e-05	0.00207	CcSEcCtD
Valrubicin—Asthenia—Docetaxel—stomach cancer	4.72e-05	0.00201	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—stomach cancer	4.66e-05	0.00198	CcSEcCtD
Valrubicin—Pruritus—Docetaxel—stomach cancer	4.65e-05	0.00198	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—stomach cancer	4.65e-05	0.00198	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—stomach cancer	4.62e-05	0.00197	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—stomach cancer	4.62e-05	0.00197	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—stomach cancer	4.57e-05	0.00194	CcSEcCtD
Valrubicin—Asthenia—Capecitabine—stomach cancer	4.57e-05	0.00194	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—stomach cancer	4.53e-05	0.00193	CcSEcCtD
Valrubicin—Pruritus—Capecitabine—stomach cancer	4.5e-05	0.00192	CcSEcCtD
Valrubicin—Diarrhoea—Docetaxel—stomach cancer	4.5e-05	0.00191	CcSEcCtD
Valrubicin—Diarrhoea—Capecitabine—stomach cancer	4.35e-05	0.00185	CcSEcCtD
Valrubicin—Dizziness—Docetaxel—stomach cancer	4.35e-05	0.00185	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.32e-05	0.00184	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—stomach cancer	4.28e-05	0.00182	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—stomach cancer	4.28e-05	0.00182	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—stomach cancer	4.23e-05	0.0018	CcSEcCtD
Valrubicin—Dizziness—Capecitabine—stomach cancer	4.21e-05	0.00179	CcSEcCtD
Valrubicin—Vomiting—Docetaxel—stomach cancer	4.18e-05	0.00178	CcSEcCtD
Valrubicin—Rash—Docetaxel—stomach cancer	4.14e-05	0.00176	CcSEcCtD
Valrubicin—Dermatitis—Docetaxel—stomach cancer	4.14e-05	0.00176	CcSEcCtD
Valrubicin—Headache—Docetaxel—stomach cancer	4.12e-05	0.00175	CcSEcCtD
Valrubicin—Vomiting—Capecitabine—stomach cancer	4.05e-05	0.00172	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.04e-05	0.00172	CcSEcCtD
Valrubicin—Rash—Capecitabine—stomach cancer	4.01e-05	0.00171	CcSEcCtD
Valrubicin—Dermatitis—Capecitabine—stomach cancer	4.01e-05	0.00171	CcSEcCtD
Valrubicin—Headache—Capecitabine—stomach cancer	3.99e-05	0.0017	CcSEcCtD
Valrubicin—Nausea—Docetaxel—stomach cancer	3.9e-05	0.00166	CcSEcCtD
Valrubicin—Feeling abnormal—Methotrexate—stomach cancer	3.9e-05	0.00166	CcSEcCtD
Valrubicin—Gastrointestinal pain—Methotrexate—stomach cancer	3.87e-05	0.00165	CcSEcCtD
Valrubicin—Nausea—Capecitabine—stomach cancer	3.78e-05	0.00161	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—stomach cancer	3.75e-05	0.00159	CcSEcCtD
Valrubicin—Body temperature increased—Methotrexate—stomach cancer	3.75e-05	0.00159	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.74e-05	0.00159	CcSEcCtD
Valrubicin—Feeling abnormal—Epirubicin—stomach cancer	3.65e-05	0.00155	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—stomach cancer	3.63e-05	0.00154	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—stomach cancer	3.5e-05	0.00149	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—stomach cancer	3.5e-05	0.00149	CcSEcCtD
Valrubicin—Asthenia—Methotrexate—stomach cancer	3.4e-05	0.00145	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—stomach cancer	3.38e-05	0.00144	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—stomach cancer	3.35e-05	0.00143	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—stomach cancer	3.35e-05	0.00143	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—stomach cancer	3.24e-05	0.00138	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—stomach cancer	3.24e-05	0.00138	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—stomach cancer	3.24e-05	0.00138	CcSEcCtD
Valrubicin—Asthenia—Epirubicin—stomach cancer	3.18e-05	0.00135	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—stomach cancer	3.14e-05	0.00133	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—stomach cancer	3.13e-05	0.00133	CcSEcCtD
Valrubicin—Diarrhoea—Epirubicin—stomach cancer	3.03e-05	0.00129	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—stomach cancer	3.01e-05	0.00128	CcSEcCtD
Valrubicin—Rash—Methotrexate—stomach cancer	2.99e-05	0.00127	CcSEcCtD
Valrubicin—Dermatitis—Methotrexate—stomach cancer	2.98e-05	0.00127	CcSEcCtD
Valrubicin—Headache—Methotrexate—stomach cancer	2.97e-05	0.00126	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—stomach cancer	2.94e-05	0.00125	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—stomach cancer	2.93e-05	0.00125	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—stomach cancer	2.9e-05	0.00123	CcSEcCtD
Valrubicin—Vomiting—Epirubicin—stomach cancer	2.82e-05	0.0012	CcSEcCtD
Valrubicin—Nausea—Methotrexate—stomach cancer	2.81e-05	0.0012	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—stomach cancer	2.81e-05	0.00119	CcSEcCtD
Valrubicin—Rash—Epirubicin—stomach cancer	2.8e-05	0.00119	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—stomach cancer	2.79e-05	0.00119	CcSEcCtD
Valrubicin—Headache—Epirubicin—stomach cancer	2.78e-05	0.00118	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—stomach cancer	2.71e-05	0.00115	CcSEcCtD
Valrubicin—Nausea—Epirubicin—stomach cancer	2.63e-05	0.00112	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—stomach cancer	2.61e-05	0.00111	CcSEcCtD
Valrubicin—Rash—Doxorubicin—stomach cancer	2.59e-05	0.0011	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—stomach cancer	2.58e-05	0.0011	CcSEcCtD
Valrubicin—Headache—Doxorubicin—stomach cancer	2.57e-05	0.00109	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—stomach cancer	2.44e-05	0.00104	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—RBP1—stomach cancer	2.44e-05	0.0585	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—ID4—stomach cancer	2.28e-05	0.0547	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—stomach cancer	1.82e-05	0.0437	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	1.8e-05	0.0432	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2D—stomach cancer	1.64e-05	0.0395	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	1.3e-05	0.0312	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—APC—stomach cancer	1.24e-05	0.0297	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—KMT2A—stomach cancer	1.11e-05	0.0267	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—stomach cancer	9.97e-06	0.024	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	8.5e-06	0.0204	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	7.82e-06	0.0188	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	7.82e-06	0.0188	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—RORA—stomach cancer	7.33e-06	0.0176	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	6.99e-06	0.0168	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	6.82e-06	0.0164	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—stomach cancer	6.82e-06	0.0164	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PRKAA1—stomach cancer	6.61e-06	0.0159	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—AHR—stomach cancer	6.55e-06	0.0157	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—MYC—stomach cancer	6.45e-06	0.0155	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—EGFR—stomach cancer	6.31e-06	0.0152	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2D—stomach cancer	6.03e-06	0.0145	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	5.93e-06	0.0142	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	5.45e-06	0.0131	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	5.39e-06	0.013	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN2D—stomach cancer	5.39e-06	0.013	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	5.32e-06	0.0128	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—TP53—stomach cancer	5.29e-06	0.0127	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	5.06e-06	0.0122	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—TYMS—stomach cancer	4.92e-06	0.0118	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	4.62e-06	0.0111	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	3.86e-06	0.00927	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—stomach cancer	3.84e-06	0.00922	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	3.8e-06	0.00912	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—AURKB—stomach cancer	3.79e-06	0.0091	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	3.73e-06	0.00896	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	3.69e-06	0.00887	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—TYMS—stomach cancer	3.58e-06	0.0086	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	3.52e-06	0.00846	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	3.41e-06	0.00818	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—AURKB—stomach cancer	3.38e-06	0.00813	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—NPM1—stomach cancer	2.98e-06	0.00716	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	2.93e-06	0.00705	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	2.91e-06	0.00698	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	2.82e-06	0.00679	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CDK4—stomach cancer	2.79e-06	0.0067	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.74e-06	0.00657	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	2.6e-06	0.00624	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	2.55e-06	0.00612	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARG—stomach cancer	2.53e-06	0.00609	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—stomach cancer	2.48e-06	0.00595	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	2.4e-06	0.00576	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	2.32e-06	0.00557	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SERPINE1—stomach cancer	2.28e-06	0.00549	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—APEX1—stomach cancer	2.17e-06	0.00522	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.12e-06	0.0051	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.08e-06	0.00499	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CHEK2—stomach cancer	2e-06	0.00481	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—MYC—stomach cancer	1.99e-06	0.00477	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	1.98e-06	0.00475	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.97e-06	0.00473	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—APEX1—stomach cancer	1.94e-06	0.00467	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.88e-06	0.00451	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.87e-06	0.0045	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.82e-06	0.00436	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—TYMS—stomach cancer	1.8e-06	0.00434	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—JUN—stomach cancer	1.8e-06	0.00432	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.77e-06	0.00426	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PPP2R1A—stomach cancer	1.77e-06	0.00425	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—MAPK8—stomach cancer	1.7e-06	0.00409	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.64e-06	0.00393	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—stomach cancer	1.62e-06	0.0039	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TYMS—stomach cancer	1.61e-06	0.00388	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.55e-06	0.00372	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.51e-06	0.00362	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.47e-06	0.00354	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.47e-06	0.00354	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—BIRC5—stomach cancer	1.45e-06	0.00349	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK4—stomach cancer	1.41e-06	0.00338	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.4e-06	0.00337	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.39e-06	0.00334	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PRKCB—stomach cancer	1.38e-06	0.00333	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.28e-06	0.00307	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDK4—stomach cancer	1.26e-06	0.00302	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PRKCB—stomach cancer	1.24e-06	0.00297	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.24e-06	0.00297	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—TP53—stomach cancer	1.19e-06	0.00285	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—IL6—stomach cancer	1.09e-06	0.00261	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—stomach cancer	1.08e-06	0.00258	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN2A—stomach cancer	9.61e-07	0.00231	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—stomach cancer	9.52e-07	0.00229	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND1—stomach cancer	9.08e-07	0.00218	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—stomach cancer	8.79e-07	0.00211	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN1B—stomach cancer	8.52e-07	0.00205	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND1—stomach cancer	8.12e-07	0.00195	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN1A—stomach cancer	7.86e-07	0.00189	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—stomach cancer	7.49e-07	0.0018	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MYC—stomach cancer	7.29e-07	0.00175	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—stomach cancer	7.13e-07	0.00171	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPK3—stomach cancer	6.7e-07	0.00161	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MYC—stomach cancer	6.52e-07	0.00157	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPK1—stomach cancer	6.37e-07	0.00153	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TP53—stomach cancer	5.35e-07	0.00129	CbGpPWpGaD
